EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 212 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,177,451 | +161.3% | 640,427 | +464.9% | 0.00% | – |
Q2 2023 | $833,240 | +147.5% | 113,366 | +248.9% | 0.00% | – |
Q1 2023 | $336,637 | -52.5% | 32,494 | -3.8% | 0.00% | – |
Q3 2022 | $709,000 | -78.6% | 33,793 | -58.1% | 0.00% | -100.0% |
Q1 2022 | $3,310,000 | -21.5% | 80,599 | -16.9% | 0.00% | 0.0% |
Q4 2021 | $4,218,000 | +10.9% | 97,012 | +27.7% | 0.00% | 0.0% |
Q3 2021 | $3,805,000 | -34.1% | 75,993 | -17.1% | 0.00% | -66.7% |
Q2 2021 | $5,773,000 | -11.7% | 91,647 | +30.3% | 0.00% | 0.0% |
Q1 2021 | $6,535,000 | -41.1% | 70,341 | -43.2% | 0.00% | -50.0% |
Q4 2020 | $11,102,000 | +125.6% | 123,908 | +160.2% | 0.01% | +100.0% |
Q3 2020 | $4,921,000 | +25.2% | 47,620 | -4.2% | 0.00% | 0.0% |
Q2 2020 | $3,929,000 | +1151.3% | 49,688 | +814.4% | 0.00% | – |
Q1 2020 | $314,000 | +16.3% | 5,434 | +8.6% | 0.00% | – |
Q4 2019 | $270,000 | -11.5% | 5,002 | -14.3% | 0.00% | -100.0% |
Q3 2019 | $305,000 | +33.2% | 5,834 | -16.5% | 0.00% | 0.0% |
Q4 2016 | $229,000 | -0.9% | 6,985 | +21.1% | 0.00% | 0.0% |
Q4 2015 | $231,000 | – | 5,770 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
AtonRa Partners | 11,505 | $472,000 | 0.26% |